{"id":"https://openalex.org/W1933713383","doi":"https://doi.org/10.18632/oncotarget.2346","title":"A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells","display_name":"A novel calcium-dependent mechanism of acquired resistance to IGF-1 receptor inhibition in prostate cancer cells","publication_year":2014,"publication_date":"2014-08-19","ids":{"openalex":"https://openalex.org/W1933713383","doi":"https://doi.org/10.18632/oncotarget.2346","mag":"1933713383","pmid":"https://pubmed.ncbi.nlm.nih.gov/25344862","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4253414"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.2346","doi":"https://doi.org/10.18632/oncotarget.2346","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.2346","pdf_url":"https://www.oncotarget.com/article/2346/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.oncotarget.com/article/2346/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002228936","display_name":"Cale D. Fahrenholtz","orcid":"https://orcid.org/0000-0002-5998-4003","observed_orcids":["https://orcid.org/0000-0002-5998-4003"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cale D Fahrenholtz","raw_affiliation_strings":["Department of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030185310","display_name":"Ann M. Greene","orcid":"https://orcid.org/0000-0003-4769-9288","observed_orcids":["https://orcid.org/0000-0003-4769-9288"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann M Greene","raw_affiliation_strings":["Department of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019770407","display_name":"Pedro J. Beltran","orcid":"https://orcid.org/0000-0002-4103-6494","observed_orcids":["https://orcid.org/0000-0002-4103-6494"]},"institutions":[{"id":"https://openalex.org/I1320553840","display_name":"Amgen (United States)","ror":"https://ror.org/03g03ge92","country_code":"US","type":"company","lineage":["https://openalex.org/I1320553840"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pedro J Beltran","raw_affiliation_strings":["Oncology Research, Amgen Inc., Thousand Oaks, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research, Amgen Inc., Thousand Oaks, CA","institution_ids":["https://openalex.org/I1320553840"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5088558562","display_name":"Kerry L. Burnstein","orcid":"https://orcid.org/0000-0002-7351-0963","observed_orcids":["https://orcid.org/0000-0002-7351-0963"]},"institutions":[{"id":"https://openalex.org/I145608581","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92","country_code":"US","type":"education","lineage":["https://openalex.org/I145608581"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kerry L Burnstein","raw_affiliation_strings":["Department of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Cellular Pharmacology, University of Miami, Miller School of Medicine, Miami, FL, USA","institution_ids":["https://openalex.org/I145608581"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5088558562"],"corresponding_institution_ids":["https://openalex.org/I145608581"],"apc_list":null,"apc_paid":null,"fwci":1.0113,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.77092856,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"5","issue":"19","first_page":"9007","last_page":"9021"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.7202000021934509,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.7202000021934509,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.27390000224113464,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.8479999899864197},{"id":"https://openalex.org/keywords/ganitumab","display_name":"ganitumab","score":0.9330000281333923},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.828000009059906},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9909999966621399},{"id":"https://openalex.org/keywords/calcium-signaling","display_name":"calcium signaling","score":0.9580000042915344},{"id":"https://openalex.org/keywords/intracellular-calcium","display_name":"intracellular calcium","score":0.6850000023841858},{"id":"https://openalex.org/keywords/mtor","display_name":"mTOR","score":0.7409999966621399},{"id":"https://openalex.org/keywords/ribosomal-protein-s6-phosphorylation","display_name":"S6 phosphorylation","score":0.7599999904632568},{"id":"https://openalex.org/keywords/phosphoproteomics","display_name":"phosphoproteomics","score":0.7400000095367432},{"id":"https://openalex.org/keywords/vcap-cells","display_name":"VCaP cells","score":0.7419999837875366},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.8040000200271606},{"id":"https://openalex.org/keywords/cell-cycle-progression","display_name":"cell cycle progression","score":0.7689999938011169},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.5569999814033508}],"concepts":[{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6771782636642456},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5126875638961792},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.49267083406448364},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44684475660324097},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.42763829231262207},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.42005354166030884},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.39768415689468384},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.321539044380188},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.304283082485199},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3017573952674866},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23464515805244446}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002118","descriptor_name":"Calcium","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011972","descriptor_name":"Receptor, Insulin","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017526","descriptor_name":"Receptor, IGF Type 1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017526","descriptor_name":"Receptor, IGF Type 1","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020013","descriptor_name":"Calcium Signaling","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D020013","descriptor_name":"Calcium Signaling","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051418","descriptor_name":"Focal Adhesion Kinase 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051418","descriptor_name":"Focal Adhesion Kinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051966","descriptor_name":"Phospholipase C gamma","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051966","descriptor_name":"Phospholipase C gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D059447","descriptor_name":"Cell Cycle Checkpoints","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065096","descriptor_name":"Calcium Chelating Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.18632/oncotarget.2346","doi":"https://doi.org/10.18632/oncotarget.2346","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.2346","pdf_url":"https://www.oncotarget.com/article/2346/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3223784","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4253414","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4253414","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4253414","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"},{"id":"pmid:25344862","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25344862","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.924.4427","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.924.4427","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"https://www.researchgate.net/profile/Cale_Fahrenholtz/publication/265785048_A_novel_calcium-dependent_mechanism_of_acquired_resistance_to_IGF-1_receptor_inhibition_in_prostate_cancer_cells/links/5421a8600cf26120b79ebe35.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.2346","doi":"https://doi.org/10.18632/oncotarget.2346","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.2346","pdf_url":"https://www.oncotarget.com/article/2346/pdf/","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2079073367","display_name":"Training Program in Cardiovascular Signaling","funder_award_id":"T32HL007188","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G5007535171","display_name":"Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.","funder_award_id":"R01CA132200","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320309249","display_name":"University of Miami","ror":"https://ror.org/02dgjyy92"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1933713383.pdf","grobid_xml":"https://content.openalex.org/works/W1933713383.grobid-xml"},"referenced_works_count":49,"referenced_works":["https://openalex.org/W39809497","https://openalex.org/W56741703","https://openalex.org/W1181096670","https://openalex.org/W1541302173","https://openalex.org/W1575074099","https://openalex.org/W1964607504","https://openalex.org/W1967224800","https://openalex.org/W1975544734","https://openalex.org/W1981354181","https://openalex.org/W1985937576","https://openalex.org/W1989854777","https://openalex.org/W1990774649","https://openalex.org/W1992166168","https://openalex.org/W1999455768","https://openalex.org/W1999859219","https://openalex.org/W2010397777","https://openalex.org/W2013523350","https://openalex.org/W2028199817","https://openalex.org/W2035104255","https://openalex.org/W2047364183","https://openalex.org/W2047822416","https://openalex.org/W2050637252","https://openalex.org/W2051839343","https://openalex.org/W2057315057","https://openalex.org/W2060600581","https://openalex.org/W2079298594","https://openalex.org/W2085391856","https://openalex.org/W2089531185","https://openalex.org/W2094145539","https://openalex.org/W2095546315","https://openalex.org/W2101179323","https://openalex.org/W2102148658","https://openalex.org/W2107294830","https://openalex.org/W2107729471","https://openalex.org/W2109250201","https://openalex.org/W2110843592","https://openalex.org/W2118861453","https://openalex.org/W2120301790","https://openalex.org/W2137288228","https://openalex.org/W2137340845","https://openalex.org/W2138405392","https://openalex.org/W2141275127","https://openalex.org/W2144824249","https://openalex.org/W2146736665","https://openalex.org/W2153232552","https://openalex.org/W2164292937","https://openalex.org/W2165491366","https://openalex.org/W2166278863","https://openalex.org/W2167156722"],"related_works":["https://openalex.org/W2009858998","https://openalex.org/W7099111251","https://openalex.org/W2109250201","https://openalex.org/W2607666604","https://openalex.org/W2561260531","https://openalex.org/W2013084670","https://openalex.org/W2159753688","https://openalex.org/W2093031239","https://openalex.org/W2773009420","https://openalex.org/W2279502259"],"abstract_inverted_index":{"//":[0],"Cale":[1],"D":[2],"Fahrenholtz":[3],"1":[4,9,19,20,88],",":[5,10,15],"Ann":[6],"M":[7],"Greene":[8],"Pedro":[11],"J":[12],"Beltran":[13],"2":[14,37],"Kerry":[16,48],"L":[17,49],"Burnstein":[18],"Department":[21],"of":[22,28,32,81,110,126,139,157,180,194,197,230,244,253,271],"Molecular":[23],"and":[24,142],"Cellular":[25],"Pharmacology,":[26],"University":[27],"Miami,":[29,34],"Miller":[30],"School":[31],"Medicine,":[33],"FL,":[35],"USA.":[36],"Oncology":[38],"Research,":[39],"Amgen":[40],"Inc.,":[41],"Thousand":[42],"Oaks,":[43],"CA.":[44],"Correspondence":[45],"to:":[46],"Dr.":[47],"Burnstein,":[50],"e-mail:":[51],"kburnstein@med.miami.edu":[52],"Key":[53],"words:":[54],"insulin-like":[55,84],"growth":[56,85],"factor":[57,86],"receptor":[58,87],"1,":[59],"ganitumab,":[60],"AMG":[61,106],"479,":[62],"phospho-proteomics,":[63],"VCaP,":[64,165],"castration":[65],"resistance":[66,131,159,203,254],"Received:":[67],"February":[68],"27,":[69],"2014":[70,74,78],"Accepted:":[71],"August":[72,76],"11,":[73],"Published:":[75],"19,":[77],"ABSTRACT":[79],"Inhibition":[80],"the":[82,101,137,155],"mitogenic":[83],"(IGF-1R)":[89],"signaling":[90,222],"axis":[91],"is":[92],"a":[93,123,140,250],"compelling":[94],"treatment":[95],"strategy":[96],"for":[97],"prostate":[98,116,147,275],"cancer.":[99,276],"Combining":[100],"IGF-1R":[102,161,256,272],"inhibitor":[103],"ganitumab":[104,172,205,238],"(formerly":[105],"479)":[107],"with":[108],"standard":[109],"care":[111],"androgen-deprivation":[112],"therapy":[113],"greatly":[114],"delays":[115],"cancer":[117,148],"recurrence":[118],"in":[119,213,219,224,267,274],"xenograft":[120],"models;":[121],"however,":[122],"significant":[124],"proportion":[125],"these":[127],"tumors":[128],"ultimately":[129],"acquire":[130],"to":[132,153,160,187,204,227,240,255],"ganitumab.":[133],"Here":[134],"we":[135],"describe":[136],"development":[138],"stable":[141],"reproducible":[143],"ganitumab-resistant":[144],"VCaP":[145],"human":[146],"cell":[149],"derivative":[150],"termed":[151],"VCaP/GanR":[152,166,174,190,225,241],"investigate":[154],"mechanism":[156,252],"acquired":[158,202],"inhibition.":[162],"Unlike":[163],"parental":[164,188],"did":[167,175],"not":[168,176,207],"undergo":[169],"apoptosis":[170],"following":[171],"treatment.":[173],"express":[177],"increased":[178,192,198,210],"levels":[179,193],"IGF-1R,":[181],"insulin":[182],"receptor,":[183],"or":[184],"phospho-AKT":[185],"compared":[186,226],"VCaP.":[189,228],"exhibited":[191],"phospho-S6":[195],"indicative":[196],"mTOR":[199,211],"activity.":[200],"However,":[201],"was":[206],"dependent":[208],"on":[209],"activity":[212],"VCaP/GanR.":[214],"Phospho-proteomic":[215],"arrays":[216],"revealed":[217],"alterations":[218],"several":[220],"calcium-regulated":[221],"components":[223],"Reduction":[229],"intracellular":[231],"calcium":[232],"using":[233],"cell-permeable":[234],"calcium-specific":[235],"chelators":[236],"restored":[237],"sensitivity":[239],"through":[242],"inhibition":[243,257],"cell-cycle":[245],"progression.":[246],"These":[247],"data":[248],"suggest":[249],"new":[251],"involving":[258],"calcium-mediated":[259],"proliferation":[260],"effects.":[261],"Such":[262],"pathways":[263],"should":[264],"be":[265],"considered":[266],"future":[268],"clinical":[269],"studies":[270],"inhibitors":[273]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}